Stock Option

NovMetaPharma Co., Ltd.

229500·KONEX·23 grants

Shares granted, cumulative
1,598,714shares
Next lockup release
D-216
2027-03-24

Against the share price

At the 2026-08-18 close
KRW
+1.1%
Shares with a reason to exercise
None
Sellable right now
None
Unrealized paper gain (to the employees)
—

Potential dilution

9.06%Against the 15% cap

Shares by strike price

  • ₩28,3009 shares
  • ₩28,10033K shares
  • ₩24,40013 shares
  • ₩19,00073K shares
  • ₩18,800200K shares
  • ₩16,40081K shares
  • ₩12,20030K shares
  • ₩5,500760K shares
  • ₩5,490Latest price

Every strike price is above the latest close, so no options currently have a reason to be exercised.

Options the share price has risen past gain a reason to be exercised and sold once the lockup ends. Filings do not show what has already been exercised or forfeited, so these figures are on a cumulative grants basis and the shares actually outstanding may be fewer.

Share price vs. strike price

A strike price is fixed on the grant date; only the share price moves. Where the price line crosses a dashed line is when that block of options first had a reason to be exercised.

Close ₩5,4902025-08-14 ~ 2026-08-18
  • Strike ₩5,500760K shares
  • Strike ₩18,800200K shares
  • Strike ₩16,40081K shares
  • Strike ₩19,00073K shares

Recipients by role

1.9MShares granted
  • Registered director21 people48%
  • Unregistered officer8 people8%
  • Employee43 people11%
  • Other · unknown27 people33%

Sorted from the relation text written in the filings (99 recipients). Officers of affiliates and subsidiaries are counted as unregistered officers. This company reported many recipients under a lumped label such as “executives and employees”, or left the field blank, so the breakdown is limited.

Shares granted by year

158K
76K
40K
148K
9
33K
230K
154K
760K
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Cumulative grants per recipient

24 named · 28 withheld
Largest holder정회윤Registered director
Top holder 13.9%Top 3 41.4%
RecipientShares, cumulativePaper gain
203,11413.9%—
200,00013.7%—
200,00013.7%—
148,79010.2%—
88,1016.0%—
70,0004.8%—
60,0004.1%—
53,8213.7%—
43,4263.0%—
34,2342.4%—

Recipients granted less than 10 in 10,000 of total shares issued have their names withheld under the disclosure rules; they cannot be split apart, so they are grouped into one row. Rows that pack several people onto one line, such as “OOO and 6 others”, are grouped there too, with the headcount read from that text — the split between them is never disclosed, so “my share” can only be prefilled with the per-person average. Filings carry no employee number or year of birth, so people with the same name are added together as one. “Exercisable” counts shares whose lockup has already ended, and any paper gain accrues to the employees holding the options.

Every figure here is parsed mechanically from the original DART filing (document.xml). “Exercise starts (estimated)” means the filing did not state an exercise period, so the date is the grant date plus two years under Article 340-2(4) of the Korean Commercial Act and may differ from the actual terms. Always read the original filing before making any decision.